Literature DB >> 2355238

Immune-mediated mechanisms in multiple sclerosis.

D Fuchs, G Reibnegger, E R Werner, H Wachter.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2355238     DOI： 10.1007/bf00314679

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  10 in total

Review 1.  Neopterin as a marker for activated cell-mediated immunity: application in HIV infection.

Authors:  D Fuchs; A Hausen; G Reibnegger; E R Werner; M P Dierich; H Wachter
Journal:  Immunol Today       Date:  1988-05

2.  Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma.

Authors:  E R Werner; G Werner-Felmayer; D Fuchs; A Hausen; G Reibnegger; H Wachter
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

3.  Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia.

Authors:  R Schwarcz; C A Tamminga; R Kurlan; I Shoulson
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

4.  CSF T-cell subsets in multiple sclerosis: relationship to cerebrospinal fluid myelin basic protein and clinical activity.

Authors:  A Salmaggi; L LaMantia; C Milanese; G Bianchi; M Eoli; A Campi; A Nespolo
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

5.  Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid.

Authors:  P Gallo; M G Piccinno; S Pagni; V Argentiero; B Giometto; F Bozza; B Tavolato
Journal:  J Neurol Sci       Date:  1989-08       Impact factor: 3.181

6.  Intrathecal production of neopterin in aseptic meningo-encephalitis and multiple sclerosis.

Authors:  S Fredrikson; P Eneroth; H Link
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

7.  Cerebrospinal fluid cells in multiple sclerosis and other neurological diseases: an immunocytochemical study.

Authors:  C H Polman; C J de Groot; J C Koetsier; T Sminia; A J Veerman
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

8.  The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.

Authors:  A S Bellamy; V L Calder; M Feldmann; A N Davison
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

9.  Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells.

Authors:  G Werner-Felmayer; E R Werner; D Fuchs; A Hausen; G Reibnegger; H Wachter
Journal:  Biol Chem Hoppe Seyler       Date:  1989-09

10.  Tumor necrosis factor identified in multiple sclerosis brain.

Authors:  F M Hofman; D R Hinton; K Johnson; J E Merrill
Journal:  J Exp Med       Date:  1989-08-01       Impact factor: 14.307
  10 in total
  2 in total

1.  Understanding the roles of the kynurenine pathway in multiple sclerosis progression.

Authors:  Chai K Lim; Bruce J Brew; Gayathri Sundaram; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2010-08-25

2.  Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis.

Authors:  Roberta Mancuso; Ambra Hernis; Simone Agostini; Marco Rovaris; Domenico Caputo; Dietmar Fuchs; Mario Clerici
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.